March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Clincal Features of Iris Melanoma in 600 Cases
Author Affiliations & Notes
  • Carlos G. Bianciotto
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • stephanie nickerson
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • carrie wright
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • bradley brocious
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • elizabeth schoenberg
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • kristen kocher
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • brittany rogers
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • fahim hashmi
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • anne hutchinson
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • carol shields
    Ocular Oncology, Wills Eye Institute, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  Carlos G. Bianciotto, None; stephanie nickerson, None; carrie wright, None; bradley brocious, None; elizabeth schoenberg, None; kristen kocher, None; brittany rogers, None; fahim hashmi, None; anne hutchinson, None; carol shields, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3384. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carlos G. Bianciotto, stephanie nickerson, carrie wright, bradley brocious, elizabeth schoenberg, kristen kocher, brittany rogers, fahim hashmi, anne hutchinson, carol shields; Clincal Features of Iris Melanoma in 600 Cases. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3384.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To analyze the clinical features and outcomes of iris melanoma from a single ocular oncology center

Methods: : Retrospective chart review

Results: : Mean patient age at presentation was 52 years, and 56% were female and 44% were male. The predominant eye color was blue in 394 patients (66%). At presentation, mean basal tumor diameter was 4.8 millimeters (mm) and mean tumor thickness was 3.5 mm. Other features included sentinel vessels in 31%, intrinsic vessels in 27%, ectropion irides in 23%, corectopia in 22%, secondary cataract in 17% iris feeder vessels in 10%, and related glaucoma in 33%. In those tumors that were excised (n=397), the predominant cell type was spindle melanoma in 55%, mixed melanoma in 42%, and epithelioid melanoma in 3%. After a mean follow up of 4 years, metastasis developed in 35 cases (6%), affecting mostly the liver (n=30, 86%). The most common treatments were excisional biopsy in 267 (45%), enucleation in 170 (28%), and plaque radiotherapy in 163 (23%).

Conclusions: : Of 600 consecutive cases of iris melanoma, the most common clinical features at presentation included sentinel (31%) and intrinsic (27%) vessels and related glaucoma in 33%. Over 4 years mean follow up, 6% developed metastatic disease.

Keywords: iris • melanoma • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×